je.st
news
Tag: proceed
HBOS bank failure review to proceed
2014-07-11 19:50:32| BBC News | Business | UK Edition
The Financial Conduct Authority says the review into why HBOS bank failed will be published by the end of the year.
Tags: review
bank
failure
proceed
AUSTRALIA: David Jones takeover meeting to proceed
2014-07-03 13:44:00| Daily apparel & textile news and comment - from just-style.com
A shareholder meeting to agree Woolworths' planned AUD2.2bn (US$2.1bn) takeover of department store retailer David Jones will proceed on 14 July following a court hearing.
Tags: david
australia
meeting
jones
Senate Trying to Proceed to AG Approps
2014-06-23 13:41:00| National Hog Farmer
By P. Scott Shearer, Bockorny Group, Washington, DC Nothing is ever easy in Congress especially during an election year and that includes trying to consider this years agriculture appropriations bill. read more
Nike waiting to proceed on World Headquarters project, 18 months after special session
2014-06-15 06:54:25| Footwear - Topix.net
The Oregon legislature met in a hastily convened special session in December 2012 with a single item on its agenda: Guaranteeing Nike favorable tax treatment in exchange for a promise to expand its headquarters in-state rather than moving jobs elsewhere.
Tags: world
special
months
project
Merck and Endocyte Announce Independent DSMB Recommends Vintafolide PROCEED Phase 3 Trial Be Stopped for Futility Following Interim Analysis
2014-05-02 14:00:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. & WEST LAFAYETTE, Ind. WHITEHOUSE STATION, N.J. & WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Endocyte, Inc. (NASDAQ:ECYT), today announced that the Data Safety Monitoring Board (DSMB) of the PROCEED trial has completed a pre-specified, interim futility analysis and the DSMB recommended that the trial be stopped because vintafolide did not demonstrate efficacy on the pre-specified outcome of Progression-Free Survival (PFS) in patients with platinum-resistant ovarian cancer. Language: English Contact: MerckMedia:Ian McConnell, +1 908-423-3046Claire Mulhearn, +1 908-423-7425orInvestors:Carol Ferguson, +1 908-423-4465Justin Holko, +1 908-423-5088orEndocyteMedia:Martina Schwarzkopf, +1 212-845-4292Tony Russo, +1 212-845-4251orInvestors:Stephanie Ascher, +1 212-362-1200 Ticker Slug: Ticker: MRK Exchange: NYSE Ticker: ECYT Exchange: NASDAQ read more
Tags: following
analysis
independent
trial
Sites : [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] next »